Living Drugs

Saxonian Precision Therapy Cluster

About Us

We are an association of leading research institutes and medical facilities from Saxony, including those in Leipzig, Dresden and Chemnitz.

Learn more on next page

Our Research

A total of 17 research projects and platforms for the production of allogeneic cell therapeutics from multiple donors in larger batches at a lower price as well as automation play an important role.

Learn more on next page

News & Press

All events, news and information about our SaxoCell cluster

Learn more on next page

Collaboration & Transfer

Overview of all technology and service offers as well as opportunities for cooperation with SaxoCell

Learn more on next page

Development of novel gene and cell therapeutics

SaxoCell has set itself the goal of developing novel gene and cell therapeutics, so-called “living drugs”, which enable this complex form of therapy to be used more widely in various areas of medicine.
The focus is on the efficacy and tolerability of these new cell therapeutics. In addition, allogeneic therapy approaches and automated manufacturing processes should enable socially acceptable costs.
The technologies developed in the cluster are developed together with local company partners and therefore represent an incentive for investors and corresponding industrial partners to get involved in the cluster region.

Latest News

23rd November 2023 | Mini-Symposium

SaxoCell Mini-Symposium on Preclinical Research Models

Our 3rd SaxoCell Mini-Symposium focussed on Preclinical Research Models and was held live at CRTD and also offered access to a large online audience.

Our speakers Prof. Renata Stripecke (University Hospital Cologne), Prof. Karsten Kretschmer (CRTD/PLID), Dr. Antje Dietrich (University Clinic Carl Gustav Carus) and Dr. Julia Schüler (Charles River Laboratories) presented on how they use mouse models to evaluate and validate their findings in the fields of CAR-T, Treg cells as well as (radio-)oncology.

The talks were accompanied by a business presentation of Charles River Laboratories who specialise in a range of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical technology and biotechnology industries, and provided an insight into their approach.

We thank all speakers and participants for their compelling talks and inspiring questions and for making this such an excellent event!

26th October 2023 | Press Release

Minister Gemkow visits Leipzig University

As part of Saxony’s “SPIN 2030” science campaign, Science Minister Sebastian Gemkow visited the Medical Department of Leipzig University on October 26, 2023.

Minister Gemkow was presented with innovative therapy options that are being researched in close cooperation with SaxoCell and are already being offered at Saxon hospitals.

Press release of Leipzig University

11th – 12th September 2023 | Meeting

Successful SaxoCell Consortium and SAB Meeting

On September 11 and 12, our SaxoCell cluster came together for its second Consortium and Scientific Advisory Board (SAB) Meeting. With about 80 participants on site and more online, we spent two wonderful days full of interesting presentations, discussions and talks.

Apart from delegates of all our projects and platforms, our SAB members as well as representatives of the German Federal Ministry of Education and Research (BMBF) and Projektträger Jülich (PtJ) were present in Leipzig or online and gave us valuable input!

We would like to thank all participants, in particular our SAB members and the representatives from BMBF and PtJ as well as our keynote speaker from BIH, Christof von Kalle!

6th September 2023 | Award

UNIPRENEURS award to SaxoCell member Frank Buchholz

Frank Buchholz was honoured as one of twenty outstanding professors & founders for his achievement in transferring innovation from university to industry.

The award recognises his enormous research success and outstanding contribution to the development of genome editing technology, especially with regard to possible therapeutic applications.

Read full TUD press release here

UNIPRENEURS website